Lazzaro Spallanzani National Institute for Infectious Diseases
The Lazzaro Spallanzani National Institute for Infectious Diseases (Italian: Istituto nazionale per le malattie infettive "L. Spallanzani") is an infectious disease hospital in the Italian city of Rome. The institute is named for the eighteenth-century Italian biologist Lazzaro Spallanzani.It is the Italian national reference center for Ebola patients.During the COVID-19 pandemic, the Spallanzani Institute was the first research centre in Europe to isolate the genomic sequence of SARS-CoV-2 and upload it to GenBank. The team was composed of Maria Rosaria Capobianchi, Francesca Colavita, and Concetta Castilletti.The institute is working with biotech company ReiThera to test a COVID-19 vaccine candidate called GRAd-COV2, which is based on a modified gorilla adenovirus vector.
Excerpt from the Wikipedia article Lazzaro Spallanzani National Institute for Infectious Diseases (License: CC BY-SA 3.0, Authors).Lazzaro Spallanzani National Institute for Infectious Diseases
Via Portuense, Rome Municipio Roma XII
Geographical coordinates (GPS) Address Phone number Website External links Nearby Places Show on map
Geographical coordinates (GPS)
| Latitude | Longitude |
|---|---|
| N 41.8662 ° | E 12.4576 ° |
Address
Istituto nazionale per le malattie infettive Lazzaro Spallanzani
Via Portuense 292
00149 Rome, Municipio Roma XII
Lazio, Italy
Open on Google Maps